Weighted Average Number of Shares Outstanding, Basic of GT Biopharma, Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
GT Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q1 2012 to Q3 2025.
  • GT Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 3.94M shares, a 76.4% increase year-over-year.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1.9M shares, a 40.8% increase from 2023.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.35M shares, a 26.9% increase from 2022.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.06M shares, a 96.2% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

GT Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 3.94M +1.71M +76.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 2.77M +1.06M +61.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 2.35M +964K +69.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 1.9M +550K +40.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-21
Q3 2024 2.23M +867K +63.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 1.71M +373K +27.8% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 1.38M +298K +27.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 1.35M +285K +26.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-21
Q3 2023 1.37M -30M -95.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 1.34M -29.9M -95.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 1.08M -31.4M -96.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 1.06M -27.1M -96.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 31.4M -648 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 31.2M -2.28M -6.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 32.5M +16.2M +100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 28.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 31.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-31
Q2 2021 33.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 16.2M -53.8M -76.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 70.1M +19M +37.2% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q1 2019 51.1M +975K +1.95% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 50.2K Oct 1, 2018 Dec 31, 2018 10-K 2019-03-29
Q3 2018 50.2M +34.1M +213% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 -0.18* +4.96 Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 50.1M +49.9M +26024% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q3 2017 16M -11.4M -41.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -5.14* -23.3M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 192K -17.2M -98.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 81.5K -2.31M -96.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 27.5M +25.1M +1044% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-28
Q2 2016 23.3M +20.9M +874% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-02-28
Q1 2016 17.4M +15M +631% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-02-28
Q4 2015 2.39M Oct 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
Q3 2015 2.4M -588M -99.6% Jul 1, 2015 Sep 30, 2015 10-Q/A 2018-02-28
Q2 2015 2.4M -571M -99.6% Apr 1, 2015 Jun 30, 2015 10-Q/A 2018-02-28
Q1 2015 2.38M -571M -99.6% Jan 1, 2015 Mar 31, 2015 10-Q/A 2018-02-28
Q3 2014 590M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 573M 0 0% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 573M +25.8M +4.72% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q2 2013 573M +244M +74% Apr 1, 2013 Jun 30, 2013 10-Q 2015-01-08
Q1 2013 547M +264M +93.4% Jan 1, 2013 Mar 31, 2013 10-Q 2015-01-08
Q2 2012 329M Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-12
Q1 2012 283M Jan 1, 2012 Mar 31, 2012 10-Q 2014-12-10

GT Biopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 1.9M +550K +40.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 1.35M +285K +26.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-21
2022 1.06M -27.1M -96.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 28.2M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2018 50.2K +33.5K Jan 1, 2018 Dec 31, 2018 10-K 2019-03-29
2017 16.8K* -64.7K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 81.5K -2.31M -96.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 2.39M Jan 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.